SOX10 and myeloid sarcoma: Although the study did not extend to detailed pathological analyses, it demonstrated a robust and efficient protocol for generating high yields of human oligodendrocytes from primary progressive MS donors, establishing a valuable platform for modelling disease-specific mechanisms in progressive MS by introducing SOX10 via lentiviral transduction.